Sponsor or institution
Clinical trials and research at Revopsis Therapeutics, INC.
As of November 12, 2026, Find a Trial lists 2 NIH-funded research projects at this institution, with $1.9 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2NIH research projects
NIH-funded research (2)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Next-generation high-affinity three-target eye protein for macular degeneration
This project is developing a new three-target antibody fragment to better treat age-related macular degeneration and other retinal diseases caused by abnormal blood vessel growth.
-
New treatment for age-related macular degeneration
This study is testing a new protein treatment for age-related macular degeneration (AMD) that aims to help improve vision and reduce the need for frequent eye injections, making it easier for older adults to manage their condition.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.